http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02233620-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44c713790ce00813da2e6c6d57a29456
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
filingDate 1989-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2c74dea1d6d085323c318ab65c5ed3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cd8b0c08f8f1719eb60e7405f68108b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_570561d84cb4cb6212c9bd58326e4fad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31011b68263bc37bbf37d0c17fd82c9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5294b044d6bea29353f561395dd4d035
publicationDate 1990-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H02233620-A
titleOfInvention Analgesic agent
abstract PURPOSE: To obtain a safe analgesic agent capable of reducing disorder in digestive tracts with hardly any side effects by blending a medium-chain fatty acid triglyceride, etc., with an acidic nonsteroidal anti-inflammatory agent. n CONSTITUTION: An analgesic agent obtained by blending (A) a substance selected from the group consisting of a medium-chain fatty acid triglyceride, propylene glycol monooleate, sorbitan ester of a fatty acid and polyoxyethylene lauryl ether with (B) an acidic nonsteroidal anti-inflammatory agent, e.g. phenylacetic acid-based derivative (e.g. ibuprofen), salicylic acid-based derivative (e.g. aspirin) or piroxicam. The amount of the ingredient (A) blended is 0.1-50 pts.wt., preferably 0.5-10 pts.wt. based on 1 pt.wt. ingredient (B). n COPYRIGHT: (C)1990,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SG-81182-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0699444-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2699405-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0699444-A2
priorityDate 1989-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226511402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471424
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406917592
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471425
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426106343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21159856
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87065672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1549559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID338
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226404047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9798043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6433267
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416129933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110

Total number of triples: 50.